A critical advance in cancer research is emerging with the use of VHH fragments to reactivate mutated p53. This crucial malignant suppressor protein is frequently inactivated in several forms of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research